VT News
Yoav Segalovich

Yoav Segalovich

Ask VT AI
View News Summary
  • Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
  • Yum! Brands names Chris Turner as new CEO, focusing on digital initiatives and value menus.
  • Trump's call for Tehran evacuation sparks market volatility and fears of wider Middle East conflict, as Iran's nuclear ambitions and military escalation add to the unsettled trading environment.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
  • Yum! Brands names Chris Turner as new CEO, focusing on digital initiatives and value menus.
  • Trump's call for Tehran evacuation sparks market volatility and fears of wider Middle East conflict, as Iran's nuclear ambitions and military escalation add to the unsettled trading environment.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Yoav Segalovich

Top Topics

Trending in U.S.

World

Sport